REV-MED International GmbH

REV-MED produces and markets the TriCell Biologic Separation & Concentration System.
The TriCell System is designed to separate autologous peripheral blood or bone marrow into its essential elements. The TriCell triple chamber technology allows for accurate customized control over the biologic. The physician can easily specify and control the final concentration and cellular constellation to meet the therapeutic demand.

Company’s Keywords:

platelet rich plasma, blood products, medical devices, aesthetic products, skin care, dermatology, orthopaedic products, wound healing